FIGORILLI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 42.658
NA - Nord America 1.033
AS - Asia 256
OC - Oceania 3
SA - Sud America 2
AF - Africa 1
Totale 43.953
Nazione #
IT - Italia 42.339
US - Stati Uniti d'America 1.031
CN - Cina 177
SE - Svezia 107
UA - Ucraina 78
DE - Germania 66
SG - Singapore 37
FI - Finlandia 20
GB - Regno Unito 20
VN - Vietnam 12
IN - India 10
KR - Corea 9
FR - Francia 7
BE - Belgio 6
AU - Australia 3
RO - Romania 3
ES - Italia 2
HK - Hong Kong 2
IQ - Iraq 2
RS - Serbia 2
RU - Federazione Russa 2
TH - Thailandia 2
TR - Turchia 2
AL - Albania 1
BG - Bulgaria 1
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
MX - Messico 1
PE - Perù 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 43.953
Città #
Cagliari 41.994
Uta 183
Chandler 135
Woodbridge 124
Fairfield 87
Nyköping 84
Ann Arbor 69
Ashburn 63
Dearborn 57
Boardman 55
Houston 46
Shanghai 42
Wilmington 35
Jacksonville 31
New York 30
Seattle 30
Cambridge 24
Nanjing 22
Boston 20
San Mateo 17
Beijing 16
Singapore 14
Dong Ket 12
Guangzhou 12
Helsinki 11
Nanchang 9
San Diego 8
Washington 8
Atlanta 6
Brussels 6
Falls Church 6
Jiaxing 6
Los Angeles 6
Rome 6
Seoul 6
Tianjin 6
Bari 5
Changsha 5
Jinan 5
Kunming 5
Ploaghe 5
Santadi 5
Sassari 5
Sìnnai 5
Hefei 4
Leawood 4
Munich 4
Norwalk 4
Paris 4
Taizhou 4
Augusta 3
Dolianova 3
Hebei 3
Milan 3
Mountain View 3
Ningbo 3
Orange 3
Pune 3
Quartu Sant'elena 3
Redwood City 3
Shenyang 3
Azzano Decimo 2
Bengaluru 2
Binasco 2
Bitonto 2
Cattolica 2
Chengdu 2
Frignano 2
Hong Kong 2
London 2
Martin de la Jara 2
Redmond 2
Shenzhen 2
Sydney 2
Wuhan 2
Zonguldak 2
Aachen 1
Ardabil 1
Azor 1
Belgrade 1
Bratislava 1
Brescia 1
Brno 1
Callao 1
Catania 1
Chiswick 1
Christiansburg 1
Cuauhtémoc 1
Dolovo 1
Gibellina 1
Jinhua 1
Lappeenranta 1
Longmont 1
Madison 1
Monmouth Junction 1
Mumbai 1
Newcastle upon Tyne 1
Nuoro 1
Olmedo 1
Pasadena 1
Totale 43.437
Nome #
Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis 4.297
Killer cell immunoglobulin-like receptors and their HLA class I ligands in autoimmune hepatitis: a possible pathogenetic role ? 3.035
HLA-G is highly expressed by plasma cells infiltrating hepatic tissue of patients affected by autoimmune hepatitis 2.977
Altered profile of salivary proteins in patients with Autoimmune Hepatitis 2.787
Role of interferon lambda 4 and ALT levels in optimising treatment of HCV for patients with low-stage fibrosis 2.685
Impact of natural killer (NK) cells receptors gene haplotypes on the development of hepatocarcinoma in cirrhotic patients 2.562
Hippocampal axis dysfunction evaluation by Rey-Osterrieth Complex figure test (RCFT) should be included in minimal hepatic encephalopathy (MHE) assessment 2.533
Combination of IFNL4 polymorphisms and ALT reduction at 4 week of treatment with PEG IFN and Ribavirin is a new selection tool to optimize antiviral treatment allocation in HCV patients with low stage fibrosis 2.449
IMPACT OF KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS ON PROGRESSION OF HEPATOCELLULAR CARCINOMA 2.345
FATTORI IMPLICATI NELLA STORIA NATURALE DELL'INFEZIONE DA VIRUS DELTA:IL RUOLO DEGLI INTERFERONI 2.333
Role of natural killercells receptors on the development and progression of hepatocellularcarcinoma 2.241
INFLUENZA DEI POLIMORFISMI DELL’INTERFERONE LAMBDA NELLA STORIA NATURALE DELLA INFEZIONE CRONICA DA HBV: COINCIDENZA O REALTÀ? 2.176
Role of HLA-G in autmoimmune hepatitis 2.142
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 2.004
Evaluation of mild cognitive dysfunction by Montreal Cognitive Assessment test in patients with chronic HCV infection treated with direct antiviral agents 1.916
Efficacy and tolerability of treatment with the new direct acting antivirals (DAAs) in thalassemic patients with chronic Hepatitis 1.772
Evaluation of mild cognitive dysfunction by Montreal Cognitive Assessment test in co-infected HIV-HCV patients treated with the new direct acting antivirals (DAAs) 1.645
SAFETY AND EFFICACY OF PEG-IFN alpha 2a AND RIBAVIRIN FOR TREATMENT OF HEPATITIS C IN SARDINIAN ADULT PATIENTS WITH THALASSEMIA MAJOR: A SINGLE CENTRE REAL LIFE EXPERIENCE 1.549
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis 567
Totale 44.015
Categoria #
all - tutte 50.565
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.565


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.054 0 0 41 82 4.210 3.208 1.583 204 136 149 117 324
2020/202114.260 328 582 513 4.674 2.742 1.474 742 839 413 840 748 365
2021/20222.142 283 191 96 169 196 137 142 103 226 202 195 202
2022/20232.562 235 386 391 211 216 171 119 163 157 180 202 131
2023/20242.943 92 391 139 234 263 406 378 194 143 148 283 272
2024/20251.813 699 750 364 0 0 0 0 0 0 0 0 0
Totale 44.015